Is it safe to outsource safety?

摘要

The need to be compliant for the increasing pharmacovigilance activities Companies are having to perform can mean that there is a lot of expense in seffing up a sophisticated approach to Drug Safety which may not provide the most cost-effective or compliant system. The article discusses the pros and cons of conducting pharmacovigilance and medical information services by outsourcing rather than trying to buy in-house expertise and the points to consider in terms of when to bring the function in-house - if at all.